Pharmacist Qualifications. Pharmacy must ensure that Pharmacist meets the following requirements prior to administering a vaccine to an individual under this Agreement.
Pharmacist Qualifications. (1) In accordance with M.G.L. c. 112, § 24B½, subsection (b), to qualify to enter into a collaborative practice agreement, a pharmacist must:
(a) hold a current unrestricted license in good standing to practice pharmacy in the Commonwealth and currently be engaged in pharmacy practice in the Commonwealth;
(b) agree to maintain at least $1,000,000 (per occurrence) of professional liability insurance during the term of the agreement which specifically covers drug therapy management;
(c) have earned a doctor of pharmacy degree or have completed five years of experience as a licensed pharmacist;
(d) agree to devote a portion of practice to the defined drug therapy area that the pharmacist shall co-manage;
(e) agree to complete, in each year of the term of the agreement, at least five additional contact hours or 0.5 continuing education units of Board-approved continuing education that address areas of practice generally related to the particular collaborative practice agreement; and
(f) if prescriptive practices are included in the collaborative practice agreement, agree to maintain a current controlled substance registration issued by the Department during the term of the agreement, pursuant to M.G.L. c. 94C, §§ 7 and 9 and 105 CMR 700.000.
Pharmacist Qualifications. (1) In accordance with M.G.L. c. 112, § 24B½, subsection (b), to qualify to enter into a collaborative practice agreement and engage in collaborative practice, a pharmacist must:
(a) hold a current unrestricted license in good standing to practice pharmacy in the Commonwealth and currently be engaged in pharmacy practice in the Commonwealth;
(b) agree to maintain at least $1,000,000 (per occurrence) of professional liability insurance during the term of the agreement which specifically covers drug therapy management;
(c) have earned a doctor of pharmacy degree or have completed five years of experience as a licensed pharmacist or have satisfied this requirement with one of the following:
1. have earned a doctor of pharmacy degree and have entered into a collaborative practice agreement on or before January 1, 2016, or
2. have completed such other education or residency criteria that the Board determines to be the equivalent of five years experience as a licensed pharmacist;
(d) agree to devote a portion of practice to the defined drug therapy area that the pharmacist shall co-manage;
(e) agree to complete, in each year of the term of the agreement, at least five additional contact hours or 0.5 continuing education units of Board-approved continuing education that address areas of practice generally related to the particular collaborative practice agreement; and
(f) if prescriptive practices are included in the collaborative practice agreement, agree to:
1. maintain a current controlled substance registration issued by the Department during the term of the agreement, pursuant to M.G.L. c. 94C,
2. complete training required pursuant to M.G.L. c. 94C, §18(e) prior to initially obtaining a controlled substance registration and at least biennially thereafter as a condition precedent to renewing his or her pharmacist license;
3. effective , submit an attestation, signed under the pains and penalties of perjury, that the pharmacist participates in, or had applied to participate in, MassHealth as either a provider of services or for the limited purpose of ordering and referring services covered by MassHealth, in accordance with M.G.L. c. 112, § 24B1/2.
(2) An authorized pharmacist participating in CDTM must maintain evidence of completion of required continuing education units for at least two years after the date of the current collaborative practice agreement.
(3) Whenever an authorized pharmacist participating in CDTM is disciplined by the Board, whether by agr...
Pharmacist Qualifications a. Have and maintain an unrestricted license in good standing to practice pharmacy in Colorado; and
b. Meet one of the following qualifications:
i. Proof of completion of a pharmacy practice and/or specialty residency or fellowship; OR
ii. Current Board Specialty Certification in Pharmacotherapy or Ambulatory Care from the Board of Pharmacy Specialties
c. Student Pharmacists may NOT practice CDTM. They may see and evaluate patients under the close and direct supervision of a pharmacist who has entered into agreement with the clinic providers. A clinical pharmacist will review all student-patient interactions.
d. Post-Graduate Year 2 (PGY2) Pharmacy Residents and fellows who meet the above qualifications may enter into CDTM agreements at the discretion of their pharmacy residency director. Post-Graduate Year 1 (PGY1) Residents may not enter CDTM agreements.
Pharmacist Qualifications. In accordance with M.G.L. c. 112, § 24B½, subsection (b), to qualify to enter into a collaborative practice agreement and engage in collaborative practice, a pharmacist must: hold a current unrestricted license in good standing to practice pharmacy in the Commonwealth and currently be engaged in pharmacy practice in the Commonwealth; agree to maintain at least $1,000,000 (per occurrence) of professional liability insurance during the term of the agreement which specifically covers drug therapy management; have earned a doctor of pharmacy degree or have completed five years of experience as a licensed pharmacist or have satisfied this requirement with one of the following:
1. have earned a doctor of pharmacy degree and have entered into a collaborative practice agreement on or before January 1, 2016, or
2. have completed such other education or residency criteria that the Board determines to be the equivalent of five years experience as a licensed pharmacist;
1. maintain a current controlled substance registration issued by the Department during the term of the agreement, pursuant to M.G.L. c. 94C, §§ 7 and 9 and 105 CMR 700.000;
3. effective __________, submit an attestation, signed under the pains and penalties of perjury, that the pharmacist participates in, or had applied to participate in, MassHealth as either a provider of services or for the limited purpose of ordering and referring services covered by MassHealth, in accordance with M.G.L. c. 112, § 24B1/2. An authorized pharmacist participating in CDTM must maintain evidence of completion of required continuing education units for at least two years after the date of the current collaborative practice agreement. Whenever an authorized pharmacist participating in CDTM is disciplined by the Board, whether by agreement or Board order, or otherwise subject to any practice restrictions, the authorized pharmacist must provide written notification of such discipline or practice restriction to each supervising physician.
Pharmacist Qualifications
